DAG1 and congenital muscular dystrophy: The atypical clinical presentation of the patient, microphthalmia and vitreous hyperplasia which are not associated with dystrophynopathy, encompass some forms of congenital muscular dystrophy caused by glycosylation defects of α-dystroglycan.